Hand Eczema Market to Reach USD 29.2 Billion by 2035, Impelled by the Development of New and More Effective Treatments, Including Biologics, Corticosteroids, and Topical Therapies BioSpace Source link
Prolonged use of oral corticosteroids in adults with atopic dermatitis (AD) was associated with a slight uptick in adverse events (AEs), a nested case-control study showed. Based on a million individuals with AD in South Korea, those who experienced AEs were more likely to have been using oral corticosteroids for longer than 90 days compared […]